Cynata Successfully Completes Share Purchase PlanIssued Capital · Market sensitive
|
Ethics Approval to Commence Clinical Trial in COVID-19Progress Report · Market sensitive
|
Cleansing NoticeIssued Capital
|
Appendix 2AIssued Capital
|
Share Purchase Plan BookletIssued Capital · Market sensitive
|
Cleansing NoticeIssued Capital
|
Appendix 2AIssued Capital
|
Quarterly Activity Report & Appendix 4CCommitments test entity quarterly reports · Market sensitive
|
Cynata announces $5.55m capital raisingIssued Capital · Market sensitive
|
Proposed Issue of SecuritiesIssued Capital
|
